UMPARRYS WITHERSPOON: Open Payments
NPI 1700336799 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $189 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 2 | $157 |
| Janssen Biotech, Inc. | 2 | $59 |
| Genmab U.S., Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
Products named: MONOFERRIC, Tivdak, TECVAYLI, LYNPARZA, DARZALEX, PLUVICTO, ELREXFIO, Polivy.
Industry payments across IN — which companies pay providers there.
